Live data from Hacker News

Viewing profile — bonsai_spool

bonsai_spool

HN member
Joined
Mon, Dec 17, 2012, 10:32 AM UTC
HN karma
2,679
Public activity
1,059 items

About bonsai_spool

Github: https://github.com/plantprelude

Recent public activity

  1. comment
    Comment #49253000

    This bonus, per the thread, has to be accepted for a candidate to get a job offer and has unclear implications for when a worker may leave. In this case it is closest to a 'signing…

  2. comment
    Comment #49239617

    > Why do you think it is not relevant to the problem of teacher recruiting? First, the issue with teacher pay is that it is low. OP and you would instead say that the issue is that…

  3. comment
    Comment #49238977

    > Teacher recruiting wouldn't be so hard if pay weren't lockstep, as it is in so many places. Unions demand this, and it keeps some potentially-effective teachers out of the profes…

  4. comment
    Comment #49227712

    The point is that this bonus is effectively a condition of hiring that has strings attached

  5. story
  6. comment
    Comment #49222643

    > You want to train kids from a young age not to spend a long time on the toilet, which reading encourages. It consistently leads to hemorrhoids. That's just a fact. Whoa, you can …

  7. comment
    Comment #49222618

    > Back when we lived without phones, we used to read instruction labels on all and any household cleaning products that were stored in the bathroom. Wow, I forgot that I used to do…

  8. story
  9. comment
    Comment #49178058

    I hear your hypotheticals about testing. I think this comes up often, by way of example, when somebody has been in the hospital for a long time. Long stays aren't always medical, t…

  10. comment
    Comment #49169429

    And written by an LLM, to boot.

  11. comment
    Comment #49167060

    I hear the complaint, all I can say is that everyone I speak to about this wants to diagnose things correctly while not wasting anybody's time or energy on bad diagnostic workups. …

  12. comment
    Comment #49166567

    I think endometriosis is common enough that it would be caught earlier ("Oh, does your joint pain get worse right before you menstruate? Tell me more"), but your point is reasonabl…

  13. comment
    Comment #49100722

    This relates to the Midjourney effort; previous HN discussions: - Original: https://news.ycombinator.com/item?id=48579650 (see https://www.nature.com/articles/s41551-026-01660-4 ) …

  14. story
  15. comment
    Comment #49060175

    Understood, I responded elsewhere that I read the Lowe article as talking about conceptual advances (ACE, HMG CoA), but I realize he's mixing both erstwhile untreated indications a…

  16. comment
    Comment #49060154

    Not being rude, and I definitely know about medicine. I explained in sibling that I understood the Lowe article to be about new research (as a researcher, I don't often think about…

  17. comment
    Comment #49060111

    I did ask for examples. These aren't really the sort of thing the article is talking about - they're just recombinations of existing medications. I admitted in another comment that…

  18. comment
    Comment #49058256

    > Why isnt it rational? You can spend that $1B to win a new category or that same money to maybe be non-inferior to Keytruda, but maybe fail. I think copycat design does happen, bu…

  19. comment
    Comment #49058184

    You are correct. I disagree with alternatives being better as a rule but these are clearly areas where there's a market (to wit, people don't like injecting themselves and prefer p…

  20. comment
    Comment #49058103

    I have seen these people, but we are speaking about drug companies making new drugs. I am not aware of an example of a new chemotherapeutic developed to reduce the side effects of …

  21. comment
    Comment #49056147

    This is very facile thinking - are there any examples of a-e in the real world (namely, a brand new drug program was spun up to exploit a-e) ? I think not, which is why I asked the…

  22. comment
    Comment #49055684

    Cost of manufacture is not a meaningful driver of pricing outside the biological How will your clinical trial of the ostensible full cure work if standard of care is curing people?…

  23. comment
    Comment #49055663

    That isn’t how a rational person would pursue this - it costs $1B to make a drug start to finish, and there’s no reason to believe your new mechanism will work. If you’re talking a…

  24. comment
    Comment #49054968

    This comment makes no sense. Why would anyone make a drug if the current prevalent treatment was as good as a functional cure? What do lorbrena and keytruda have to do with the rat…

  25. comment
    Comment #49014444

    Wow, you’re my twin! I’d watch these on XBMC/Xbox Media Center with some other video podcasts - it was a magical moment in tech